Point-of-care lactate testing predicts mortality of severe sepsis in a predominantly HIV type 1-infected patient population in Uganda

Clinical Infectious Diseases

Volumn 46, Issue 2, 2008, Pages 215-222

  Moore, Christopher C ^a   Jacob, Shevin T ^a   Pinkerton, Relana ^a   Meya, David B ^d   Mayanja Kizza, Harriet ^d   Reynolds, Steven J ^b,c   Scheld, W Michael ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MAKERERE UNIVERSITY   (Uganda)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; EFAVIRENZ PLUS EMTRICITABINE PLUS TENOFOVIR; EFAVIRENZ PLUS LAMIVUDINE PLUS STAVUDINE; EFAVIRENZ PLUS LAMIVUDINE PLUS ZIDOVUDINE; EMTRICITABINE PLUS LOPINAVIR PLUS RITONAVIR PLUS TENOFOVIR; LACTIC ACID; LAMIVUDINE PLUS NEVIRAPINE PLUS STAVUDINE; NEVIRAPINE PLUS STAVUDINE PLUS ZIDOVUDINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL DECISION MAKING; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; FEMALE; HOSPITAL PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HYPOTENSION; LABORATORY TEST; LACTATE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; OUTPATIENT; PATIENT REFERRAL; POINT OF CARE TESTING; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; UGANDA;

ADULT; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; LACTIC ACID; MALE; POINT-OF-CARE SYSTEMS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; SEPSIS; UGANDA;

EID: 39449119819     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/524665     Document Type: Article

References (25)

1. Joint United Nations Programme on HIV/AIDS (UNAIDS), World Health Organization. Report on the global AIDS epidemic 2006. UNAIDS 2006. Available at: http://www.unaids.org/en/HIV_data/2006GlobalReport/default.asp. Accessed 29 November 2007.
2. Petti CA, Polage CR, Quinn TC, Ronald AR, Sande MA. Laboratory medicine in Africa: a barrier to effective health care. Clin Infect Dis 2006; 42:377-82.
3. Wachter RM, Luce JM, Turner J, Volberding P, Hopewell PC. Intensive care of patients with the acquired immunodeficiency syndrome: outcome and changing patterns of utilization. Am Rev Respir Dis 1986; 134:891-6.
4. Huang L, Quartin A, Jones D, Havlir DV. Intensive care of patients with HIV infection. N Engl J Med 2006; 355:173-81.
5. Nickas G, Wachter RM. Outcomes of intensive care for patients with human immunodeficiency virus infection. Arch Intern Med 2000; 160:541-7.
6. Morris A, Creasman J, Turner J, Luce JM, Wachter RM, Huang L. Intensive care of human immunodeficiency virus-infected patients during the era of highly active antiretroviral therapy. Am J Respir Crit Care Med 2002; 166:262-7.
7. Berkley JA, Lowe BS, Mwangi I, et al. Bacteremia among children admitted to a rural hospital in Kenya. N Engl J Med 2005; 352:39-47.
8. Ssali FN, Kamya MR, Wabwire-Mangen F, et al. A prospective study of community-acquired bloodstream infections among febrile adults admitted to Mulago Hospital in Kampala, Uganda. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 19:484-9.
9. Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP. The natural history of the systemic inflammatory response syndrome (SIRS): a prospective study. JAMA 1995; 273:117-23.
10. Aduen J, Bernstein WK, Khastgir T, et al. The use and clinical importance of a substrate-specific electrode for rapid determination of blood lactate concentrations. JAMA 1994; 272:1678-85.
11. Shapiro NI, Howell MD, Talmor D, et al. Serum lactate as a predictor of mortality in emergency department patients with infection. Ann Emerg Med 2005; 45:524-8.
12. Nguyen HB, Rivers EP, Knoblich BP, et al. Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Crit Care Med 2004; 32:1637-42.
13. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345:1368-77.
14. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1:307-10.
15. Bates I, Bekoe V, Asamoa-Adu A. Improving the accuracy of malaria-related laboratory tests in Ghana. Malar J 2004; 3:38.
16. Ivers LC, Mukherjee JS. Point of care testing for antiretroviral therapy-related lactic acidosis in resource-poor settings. AIDS 2006; 20:779-80.
17. Bakker J, Coffernils M, Leon M, Gris P, Vincent JL. Blood lactate levels are superior to oxygen-derived variables in predicting outcome in human septic shock. Chest 1991; 99:956-62.
18. Bishop D. Evaluation of the Accusport lactate analyser. Int J Sports Med 2001; 22:525-30.
19. Slomovitz BM, Lavery RF, Tortella BJ, Siegel JH, Bachl BL, Ciccone A. Validation of a hand-held lactate device in determination of blood lactate in critically injured patients. Crit Care Med 1998; 26:1523-8.
20. Boldt J, Kumle B, Suttner S, Haisch G. Point-of-care (POC) testing of lactate in the intensive care patient: accuracy, reliability, and costs of different measurement systems. Acta Anaesthesiol Scand 2001; 45:194-9.
21. Evans JA, Adusei A, Timmann C, et al. High mortality of infant bacteraemia clinically indistinguishable from severe malaria. QJM 2004; 97:591-7.
22. Amexo M, Tolhurst R, Barnish G, Bates I. Malaria misdiagnosis: effects on the poor and vulnerable. Lancet 2004; 364:1896-8.
23. Reyburn H, Mbakilwa H, Mwangi R, et al. Rapid diagnostic tests compared with malaria microscopy for guiding outpatient treatment of febrile illness in Tanzania: randomised trial. BMJ 2007; 334:403.
24. Mundy C, Ngwira M, Kadewele G, Bates I, Squire SB, Gilks CF. Evaluation of microscope condition in Malawi. Trans R Soc Trop Med Hyg 2000; 94:583-4.
25. Gilks CF, Crowley S, Ekpini R, et al. The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings. Lancet 2006; 368:505-10.